_id
6915ebadbc934aba376b1cfb
Ticker
QURE
Name
Uniqure NV
Exchange
NASDAQ
Address
Paasheuvelweg 25, Amsterdam, Netherlands, 1105 BP
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.uniqure.com
Description
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Last Close
19.75
Volume
1836277
Current Price
19.51
Change
-1.2151898734177136
Last Updated
2025-12-03T12:41:26.767Z
Image
data:image/webp;base64,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
Ipo Date
2007-06-20T00:00:00.000Z
Market Cap
1577224960
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.5666470588235294
Sentiment Sources
17
Rating
4.5385
Target Price
58.7856
Strong Buy
9
Buy
2
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
3701000
Cost Of Revenue
398000
Gross Profit
3303000
Operating Expenses
54338000
Operating Income
-51035000
Interest Expense
16721000
Pretax Income
-71903000
Net Income
-80529000
Eps
-1.3761779493839463
Dividends Per Share
-
Shares Outstanding
62291663
Income Tax Expense
8626000
EBITDA
-51550000
Operating Margin
-1378.9516346933262
Total Other Income Expense Net
-20868000
Cash
597056000
Short Term Investments
97189000
Receivables
3883000
Inventories
-
Total Current Assets
716193000
Property Plant Equipment
28481000
Total Assets
888382000
Payables
6228000
Short Term Debt
3914000
Long Term Debt
51880000
Total Liabilities
659636000
Equity
228746000
Depreciation
3632000
Change In Working Capital
40451000
Cash From Operations
-16399000
Capital Expenditures
66000
Cash From Investing
26579000
Cash From Financing
332235000
Net Change In Cash
343277000
PE
-
PB
4.990929925113445
ROE
-35.20455002491847
ROA
-9.06468163470219
FCF
-16465000
Fcf Percent
-4.448797622264253
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
3701000
Quarters > 0 > income Statement > cost Of Revenue
398000
Quarters > 0 > income Statement > gross Profit
3303000
Quarters > 0 > income Statement > operating Expenses
54338000
Quarters > 0 > income Statement > operating Income
-51035000
Quarters > 0 > income Statement > interest Expense
16721000
Quarters > 0 > income Statement > pretax Income
-71903000
Quarters > 0 > income Statement > net Income
-80529000
Quarters > 0 > income Statement > eps
-1.3761779493839463
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
58516415
Quarters > 0 > income Statement > income Tax Expense
8626000
Quarters > 0 > income Statement > EBITDA
-51550000
Quarters > 0 > income Statement > operating Margin
-1378.9516346933262
Quarters > 0 > income Statement > total Other Income Expense Net
-20868000
Quarters > 0 > balance Sheet > cash
597056000
Quarters > 0 > balance Sheet > short Term Investments
97189000
Quarters > 0 > balance Sheet > receivables
3883000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
716193000
Quarters > 0 > balance Sheet > property Plant Equipment
28481000
Quarters > 0 > balance Sheet > total Assets
888382000
Quarters > 0 > balance Sheet > payables
6228000
Quarters > 0 > balance Sheet > short Term Debt
3914000
Quarters > 0 > balance Sheet > long Term Debt
51880000
Quarters > 0 > balance Sheet > total Liabilities
659636000
Quarters > 0 > balance Sheet > equity
228746000
Quarters > 0 > cash Flow > net Income
-80529000
Quarters > 0 > cash Flow > depreciation
3632000
Quarters > 0 > cash Flow > change In Working Capital
40451000
Quarters > 0 > cash Flow > cash From Operations
-16399000
Quarters > 0 > cash Flow > capital Expenditures
66000
Quarters > 0 > cash Flow > cash From Investing
26579000
Quarters > 0 > cash Flow > cash From Financing
332235000
Quarters > 0 > cash Flow > net Change In Cash
343277000
Quarters > 0 > ratios > PE
-1.3761779493839463
Quarters > 0 > ratios > PB
4.990929925113445
Quarters > 0 > ratios > ROE
-35.20455002491847
Quarters > 0 > ratios > ROA
-9.06468163470219
Quarters > 0 > ratios > FCF
-16465000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.448797622264253
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5262000
Quarters > 1 > income Statement > cost Of Revenue
656000
Quarters > 1 > income Statement > gross Profit
4606000
Quarters > 1 > income Statement > operating Expenses
48471000
Quarters > 1 > income Statement > operating Income
-43865000
Quarters > 1 > income Statement > interest Expense
15591000
Quarters > 1 > income Statement > pretax Income
-37294000
Quarters > 1 > income Statement > net Income
-37719000
Quarters > 1 > income Statement > eps
-0.6882028665650014
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
54807967
Quarters > 1 > income Statement > income Tax Expense
425000
Quarters > 1 > income Statement > EBITDA
-18073000
Quarters > 1 > income Statement > operating Margin
-833.6183960471304
Quarters > 1 > income Statement > total Other Income Expense Net
6571000
Quarters > 1 > balance Sheet > cash
253778000
Quarters > 1 > balance Sheet > short Term Investments
123196000
Quarters > 1 > balance Sheet > receivables
5606000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
408573000
Quarters > 1 > balance Sheet > property Plant Equipment
31127000
Quarters > 1 > balance Sheet > total Assets
584890000
Quarters > 1 > balance Sheet > payables
5541000
Quarters > 1 > balance Sheet > short Term Debt
3909000
Quarters > 1 > balance Sheet > long Term Debt
51842000
Quarters > 1 > balance Sheet > total Liabilities
588893000
Quarters > 1 > balance Sheet > equity
-4003000
Quarters > 1 > cash Flow > net Income
-37719000
Quarters > 1 > cash Flow > depreciation
-3630000
Quarters > 1 > cash Flow > change In Working Capital
-6053000
Quarters > 1 > cash Flow > cash From Operations
-39895000
Quarters > 1 > cash Flow > capital Expenditures
260000
Quarters > 1 > cash Flow > cash From Investing
73073000
Quarters > 1 > cash Flow > cash From Financing
44000
Quarters > 1 > cash Flow > net Change In Cash
36614000
Quarters > 1 > ratios > PE
-0.6882028665650014
Quarters > 1 > ratios > PB
-267.1255149063203
Quarters > 1 > ratios > ROE
942.2682987759181
Quarters > 1 > ratios > ROA
-6.448904922293081
Quarters > 1 > ratios > FCF
-40155000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-7.631128848346636
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1567000
Quarters > 2 > income Statement > cost Of Revenue
197000
Quarters > 2 > income Statement > gross Profit
1370000
Quarters > 2 > income Statement > operating Expenses
40701000
Quarters > 2 > income Statement > operating Income
-39331000
Quarters > 2 > income Statement > interest Expense
15109000
Quarters > 2 > income Statement > pretax Income
-43141000
Quarters > 2 > income Statement > net Income
-43637000
Quarters > 2 > income Statement > eps
-0.821618873679652
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
53111000
Quarters > 2 > income Statement > income Tax Expense
496000
Quarters > 2 > income Statement > EBITDA
-23505000
Quarters > 2 > income Statement > operating Margin
-2509.955328653478
Quarters > 2 > income Statement > total Other Income Expense Net
-3810000
Quarters > 2 > balance Sheet > cash
217229000
Quarters > 2 > balance Sheet > short Term Investments
191782000
Quarters > 2 > balance Sheet > receivables
2522000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
435421000
Quarters > 2 > balance Sheet > property Plant Equipment
31547000
Quarters > 2 > balance Sheet > total Assets
605403000
Quarters > 2 > balance Sheet > payables
5268000
Quarters > 2 > balance Sheet > short Term Debt
3698000
Quarters > 2 > balance Sheet > long Term Debt
51592000
Quarters > 2 > balance Sheet > total Liabilities
571717000
Quarters > 2 > balance Sheet > equity
33686000
Quarters > 2 > cash Flow > net Income
-43637000
Quarters > 2 > cash Flow > depreciation
4527000
Quarters > 2 > cash Flow > change In Working Capital
-6277000
Quarters > 2 > cash Flow > cash From Operations
-44100000
Quarters > 2 > cash Flow > capital Expenditures
126000
Quarters > 2 > cash Flow > cash From Investing
20099000
Quarters > 2 > cash Flow > cash From Financing
80670000
Quarters > 2 > cash Flow > net Change In Cash
58329000
Quarters > 2 > ratios > PE
-0.821618873679652
Quarters > 2 > ratios > PB
30.76042302440183
Quarters > 2 > ratios > ROE
-129.54046191296086
Quarters > 2 > ratios > ROA
-7.207925960062966
Quarters > 2 > ratios > FCF
-44226000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-28.223356732610082
Quarters > 2 > health Score
8
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
5221000
Quarters > 3 > income Statement > cost Of Revenue
619000
Quarters > 3 > income Statement > gross Profit
4602000
Quarters > 3 > income Statement > operating Expenses
50430000
Quarters > 3 > income Statement > operating Income
-45828000
Quarters > 3 > income Statement > interest Expense
14876000
Quarters > 3 > income Statement > pretax Income
-72405000
Quarters > 3 > income Statement > net Income
-73261000
Quarters > 3 > income Statement > eps
-1.5000000204747412
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
48840666
Quarters > 3 > income Statement > income Tax Expense
856000
Quarters > 3 > income Statement > EBITDA
-53173000
Quarters > 3 > income Statement > operating Margin
-877.7628806742003
Quarters > 3 > income Statement > total Other Income Expense Net
-26577000
Quarters > 3 > balance Sheet > cash
158930000
Quarters > 3 > balance Sheet > short Term Investments
208591000
Quarters > 3 > balance Sheet > receivables
5881000
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
390289000
Quarters > 3 > balance Sheet > property Plant Equipment
34071000
Quarters > 3 > balance Sheet > total Assets
556536000
Quarters > 3 > balance Sheet > payables
7227000
Quarters > 3 > balance Sheet > short Term Debt
3601000
Quarters > 3 > balance Sheet > long Term Debt
51324000
Quarters > 3 > balance Sheet > total Liabilities
563288000
Quarters > 3 > balance Sheet > equity
-6752000
Quarters > 3 > cash Flow > net Income
-73261000
Quarters > 3 > cash Flow > depreciation
4356000
Quarters > 3 > cash Flow > change In Working Capital
12290000
Quarters > 3 > cash Flow > cash From Operations
-52844000
Quarters > 3 > cash Flow > capital Expenditures
61000
Quarters > 3 > cash Flow > cash From Investing
-26624000
Quarters > 3 > cash Flow > cash From Financing
-6517000
Quarters > 3 > cash Flow > net Change In Cash
-92750000
Quarters > 3 > ratios > PE
-1.5000000204747412
Quarters > 3 > ratios > PB
-141.12579882405214
Quarters > 3 > ratios > ROE
1085.0266587677725
Quarters > 3 > ratios > ROA
-13.163748616441703
Quarters > 3 > ratios > FCF
-52905000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-10.133116261252633
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
27119000
Annuals > 0 > income Statement > cost Of Revenue
18327000
Annuals > 0 > income Statement > gross Profit
8792000
Annuals > 0 > income Statement > operating Expenses
193086000
Annuals > 0 > income Statement > operating Income
-184294000
Annuals > 0 > income Statement > interest Expense
63741000
Annuals > 0 > income Statement > pretax Income
-237127000
Annuals > 0 > income Statement > net Income
-239556000
Annuals > 0 > income Statement > eps
-4.924171103208699
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
48649000
Annuals > 0 > income Statement > income Tax Expense
2429000
Annuals > 0 > income Statement > EBITDA
-160745000
Annuals > 0 > income Statement > operating Margin
-679.5752055754268
Annuals > 0 > income Statement > total Other Income Expense Net
-52833000
Annuals > 0 > balance Sheet > cash
158930000
Annuals > 0 > balance Sheet > short Term Investments
208591000
Annuals > 0 > balance Sheet > receivables
5881000
Annuals > 0 > balance Sheet > inventories
0
Annuals > 0 > balance Sheet > total Current Assets
390289000
Annuals > 0 > balance Sheet > property Plant Equipment
34071000
Annuals > 0 > balance Sheet > total Assets
556536000
Annuals > 0 > balance Sheet > payables
7227000
Annuals > 0 > balance Sheet > short Term Debt
3601000
Annuals > 0 > balance Sheet > long Term Debt
51324000
Annuals > 0 > balance Sheet > total Liabilities
563288000
Annuals > 0 > balance Sheet > equity
-6752000
Annuals > 0 > cash Flow > net Income
-239556000
Annuals > 0 > cash Flow > depreciation
12641000
Annuals > 0 > cash Flow > change In Working Capital
-3944000
Annuals > 0 > cash Flow > cash From Operations
-182728000
Annuals > 0 > cash Flow > capital Expenditures
3368000
Annuals > 0 > cash Flow > cash From Investing
162968000
Annuals > 0 > cash Flow > cash From Financing
-59486000
Annuals > 0 > cash Flow > net Change In Cash
-84215000
Annuals > 0 > ratios > PE
-4.924171103208699
Annuals > 0 > ratios > PB
-182.43375000000003
Annuals > 0 > ratios > ROE
3547.9265402843603
Annuals > 0 > ratios > ROA
-43.04411574453405
Annuals > 0 > ratios > FCF
-186096000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6.862199933625871
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
15843000
Annuals > 1 > income Statement > cost Of Revenue
13628000
Annuals > 1 > income Statement > gross Profit
2215000
Annuals > 1 > income Statement > operating Expenses
285086000
Annuals > 1 > income Statement > operating Income
-282871000
Annuals > 1 > income Statement > interest Expense
41557000
Annuals > 1 > income Statement > pretax Income
-306557000
Annuals > 1 > income Statement > net Income
-308478000
Annuals > 1 > income Statement > eps
-6.470980063219167
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
47670986
Annuals > 1 > income Statement > income Tax Expense
1921000
Annuals > 1 > income Statement > EBITDA
-253100000
Annuals > 1 > income Statement > operating Margin
-1785.4636116897052
Annuals > 1 > income Statement > total Other Income Expense Net
-23686000
Annuals > 1 > balance Sheet > cash
241360000
Annuals > 1 > balance Sheet > short Term Investments
376532000
Annuals > 1 > balance Sheet > receivables
4193000
Annuals > 1 > balance Sheet > inventories
12024000
Annuals > 1 > balance Sheet > total Current Assets
651853000
Annuals > 1 > balance Sheet > property Plant Equipment
75337000
Annuals > 1 > balance Sheet > total Assets
831689000
Annuals > 1 > balance Sheet > payables
6586000
Annuals > 1 > balance Sheet > short Term Debt
8344000
Annuals > 1 > balance Sheet > long Term Debt
101749000
Annuals > 1 > balance Sheet > total Liabilities
624019000
Annuals > 1 > balance Sheet > equity
207670000
Annuals > 1 > cash Flow > net Income
-308478000
Annuals > 1 > cash Flow > depreciation
11900000
Annuals > 1 > cash Flow > change In Working Capital
81123000
Annuals > 1 > cash Flow > cash From Operations
-145929000
Annuals > 1 > cash Flow > capital Expenditures
7154000
Annuals > 1 > cash Flow > cash From Investing
-205686000
Annuals > 1 > cash Flow > cash From Financing
362721000
Annuals > 1 > cash Flow > net Change In Cash
13371000
Annuals > 1 > ratios > PE
-6.470980063219167
Annuals > 1 > ratios > PB
5.812247149419753
Annuals > 1 > ratios > ROE
-148.54239899841093
Annuals > 1 > ratios > ROA
-37.09054706747354
Annuals > 1 > ratios > FCF
-153083000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-9.662500788991984
Annuals > 1 > health Score
11
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
106483000
Annuals > 2 > income Statement > cost Of Revenue
3343000
Annuals > 2 > income Statement > gross Profit
103140000
Annuals > 2 > income Statement > operating Expenses
246299000
Annuals > 2 > income Statement > operating Income
-143159000
Annuals > 2 > income Statement > interest Expense
11704000
Annuals > 2 > income Statement > pretax Income
-128259000
Annuals > 2 > income Statement > net Income
-126789000
Annuals > 2 > income Statement > eps
-2.7129320192159865
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
46735045
Annuals > 2 > income Statement > income Tax Expense
-1470000
Annuals > 2 > income Statement > EBITDA
-108018000
Annuals > 2 > income Statement > operating Margin
-134.44305663814882
Annuals > 2 > income Statement > total Other Income Expense Net
14900000
Annuals > 2 > balance Sheet > cash
228012000
Annuals > 2 > balance Sheet > short Term Investments
124831000
Annuals > 2 > balance Sheet > receivables
102376000
Annuals > 2 > balance Sheet > inventories
6924000
Annuals > 2 > balance Sheet > total Current Assets
476774000
Annuals > 2 > balance Sheet > property Plant Equipment
83258000
Annuals > 2 > balance Sheet > total Assets
704964000
Annuals > 2 > balance Sheet > payables
10984000
Annuals > 2 > balance Sheet > short Term Debt
8382000
Annuals > 2 > balance Sheet > long Term Debt
102791000
Annuals > 2 > balance Sheet > total Liabilities
228955000
Annuals > 2 > balance Sheet > equity
476009000
Annuals > 2 > cash Flow > net Income
-126789000
Annuals > 2 > cash Flow > depreciation
8537000
Annuals > 2 > cash Flow > change In Working Capital
-43384000
Annuals > 2 > cash Flow > cash From Operations
-145060000
Annuals > 2 > cash Flow > capital Expenditures
17688000
Annuals > 2 > cash Flow > cash From Investing
-182734000
Annuals > 2 > cash Flow > cash From Financing
1445000
Annuals > 2 > cash Flow > net Change In Cash
-328180000
Annuals > 2 > ratios > PE
-2.7129320192159865
Annuals > 2 > ratios > PB
2.485943205695691
Annuals > 2 > ratios > ROE
-26.635840918974218
Annuals > 2 > ratios > ROA
-17.98517371099801
Annuals > 2 > ratios > FCF
-162748000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.5283942037696159
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
524002000
Annuals > 3 > income Statement > cost Of Revenue
24976000
Annuals > 3 > income Statement > gross Profit
499026000
Annuals > 3 > income Statement > operating Expenses
188408000
Annuals > 3 > income Statement > operating Income
310618000
Annuals > 3 > income Statement > interest Expense
7474000
Annuals > 3 > income Statement > pretax Income
332806000
Annuals > 3 > income Statement > net Income
329589000
Annuals > 3 > income Statement > eps
7.036339894910806
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
46840972
Annuals > 3 > income Statement > income Tax Expense
3217000
Annuals > 3 > income Statement > EBITDA
319000000
Annuals > 3 > income Statement > operating Margin
59.27801802283197
Annuals > 3 > income Statement > total Other Income Expense Net
22188000
Annuals > 3 > balance Sheet > cash
556256000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
58768000
Annuals > 3 > balance Sheet > inventories
10540000
Annuals > 3 > balance Sheet > total Current Assets
628239000
Annuals > 3 > balance Sheet > property Plant Equipment
69078000
Annuals > 3 > balance Sheet > total Assets
809180000
Annuals > 3 > balance Sheet > payables
2502000
Annuals > 3 > balance Sheet > short Term Debt
5774000
Annuals > 3 > balance Sheet > long Term Debt
100963000
Annuals > 3 > balance Sheet > total Liabilities
213404000
Annuals > 3 > balance Sheet > equity
595776000
Annuals > 3 > cash Flow > net Income
329589000
Annuals > 3 > cash Flow > depreciation
7299000
Annuals > 3 > cash Flow > change In Working Capital
-50482000
Annuals > 3 > cash Flow > cash From Operations
287959000
Annuals > 3 > cash Flow > capital Expenditures
17438000
Annuals > 3 > cash Flow > cash From Investing
-67387000
Annuals > 3 > cash Flow > cash From Financing
94858000
Annuals > 3 > cash Flow > net Change In Cash
311673000
Annuals > 3 > ratios > PE
7.036339894910806
Annuals > 3 > ratios > PB
1.9907035715436674
Annuals > 3 > ratios > ROE
55.32095955526909
Annuals > 3 > ratios > ROA
40.73123408883067
Annuals > 3 > ratios > FCF
270521000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.5162594799256491
Annuals > 3 > health Score
93
Valuation > metrics > PE
-1.3761779493839463
Valuation > metrics > PB
4.990929925113445
Valuation > final Score
30.09070074886555
Valuation > verdict
66.4% Overvalued
Profitability > metrics > ROE
-35.20455002491847
Profitability > metrics > ROA
-11.244036174606565
Profitability > metrics > Net Margin
-21.758713861118615
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.8837050702525944
Risk > metrics > Interest Coverage
-3.0521499910292444
Risk > final Score
6
Risk > verdict
High
Liquidity > metrics > Current Ratio
70.61654506014592
Liquidity > metrics > Quick Ratio
70.61654506014592
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
40
Prev Risks > 0
19
Prev Risks > 1
-4
Prev Risks > 2
18
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:16:05.933Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.9068
Earnings History > 0 > eps Difference
0.9068
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.38
Earnings History > 1 > eps Estimate
-0.91
Earnings History > 1 > eps Difference
-0.47
Earnings History > 1 > surprise Percent
-51.6484
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-29
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.69
Earnings History > 2 > eps Estimate
-0.89
Earnings History > 2 > eps Difference
0.2
Earnings History > 2 > surprise Percent
22.4719
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-18
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.7278
Earnings History > 3 > eps Estimate
-0.8863
Earnings History > 3 > eps Difference
0.1585
Earnings History > 3 > surprise Percent
17.8833
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-24
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.4415
Earnings History > 4 > eps Estimate
-0.517
Earnings History > 4 > eps Difference
-0.9245
Earnings History > 4 > surprise Percent
-178.8201
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.91
Earnings History > 5 > eps Estimate
-1.02
Earnings History > 5 > eps Difference
0.11
Earnings History > 5 > surprise Percent
10.7843
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-01
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.16
Earnings History > 6 > eps Estimate
-1.25
Earnings History > 6 > eps Difference
0.09
Earnings History > 6 > surprise Percent
7.2
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.36
Earnings History > 7 > eps Estimate
-1.28
Earnings History > 7 > eps Difference
-0.08
Earnings History > 7 > surprise Percent
-6.25
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.53
Earnings History > 8 > eps Estimate
-1.46
Earnings History > 8 > eps Difference
-0.07
Earnings History > 8 > surprise Percent
-4.7945
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.88
Earnings History > 9 > eps Estimate
-0.85
Earnings History > 9 > eps Difference
-1.03
Earnings History > 9 > surprise Percent
-121.1765
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-01
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.44
Earnings History > 10 > eps Estimate
2.05
Earnings History > 10 > eps Difference
-3.49
Earnings History > 10 > surprise Percent
-170.2439
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-1.63
Earnings History > 11 > eps Estimate
-0.95
Earnings History > 11 > eps Difference
-0.68
Earnings History > 11 > surprise Percent
-71.5789
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.15
Earnings History > 12 > eps Estimate
-0.89
Earnings History > 12 > eps Difference
1.04
Earnings History > 12 > surprise Percent
116.8539
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-02
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.02
Earnings History > 13 > eps Estimate
-1.16
Earnings History > 13 > eps Difference
0.14
Earnings History > 13 > surprise Percent
12.069
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.84
Earnings History > 14 > eps Estimate
-1
Earnings History > 14 > eps Difference
0.16
Earnings History > 14 > surprise Percent
16
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-02
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1
Earnings History > 15 > eps Estimate
-0.93
Earnings History > 15 > eps Difference
-0.07
Earnings History > 15 > surprise Percent
-7.5269
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-25
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.17
Earnings History > 16 > eps Estimate
-0.81
Earnings History > 16 > eps Difference
0.98
Earnings History > 16 > surprise Percent
120.9877
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-25
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.79
Earnings History > 17 > eps Estimate
-1.05
Earnings History > 17 > eps Difference
0.26
Earnings History > 17 > surprise Percent
24.7619
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-26
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
8.51
Earnings History > 18 > eps Estimate
2.96
Earnings History > 18 > eps Difference
5.55
Earnings History > 18 > surprise Percent
187.5
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.91
Earnings History > 19 > eps Estimate
-0.88
Earnings History > 19 > eps Difference
-0.03
Earnings History > 19 > surprise Percent
-3.4091
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-01
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.01
Earnings History > 20 > eps Estimate
1.52
Earnings History > 20 > eps Difference
-1.53
Earnings History > 20 > surprise Percent
-100.6579
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-27
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.21
Earnings History > 21 > eps Estimate
1.65
Earnings History > 21 > eps Difference
-2.86
Earnings History > 21 > surprise Percent
-173.3333
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.96
Earnings History > 22 > eps Estimate
-0.67
Earnings History > 22 > eps Difference
-0.29
Earnings History > 22 > surprise Percent
-43.2836
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-04-29
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.63
Earnings History > 23 > eps Estimate
-0.84
Earnings History > 23 > eps Difference
0.21
Earnings History > 23 > surprise Percent
25
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-02
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.96
Earnings History > 24 > eps Estimate
-0.73
Earnings History > 24 > eps Difference
-0.23
Earnings History > 24 > surprise Percent
-31.5068
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-10-28
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.58
Earnings History > 25 > eps Estimate
-0.81
Earnings History > 25 > eps Difference
0.23
Earnings History > 25 > surprise Percent
28.3951
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-07-29
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.83
Earnings History > 26 > eps Estimate
-0.75
Earnings History > 26 > eps Difference
-0.08
Earnings History > 26 > surprise Percent
-10.6667
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-04-29
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.74
Earnings History > 27 > eps Estimate
-0.71
Earnings History > 27 > eps Difference
-0.03
Earnings History > 27 > surprise Percent
-4.2254
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-28
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.59
Earnings History > 28 > eps Estimate
-0.66
Earnings History > 28 > eps Difference
0.07
Earnings History > 28 > surprise Percent
10.6061
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-06
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.59
Earnings History > 29 > eps Estimate
-0.62
Earnings History > 29 > eps Difference
0.03
Earnings History > 29 > surprise Percent
4.8387
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-08
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.57
Earnings History > 30 > eps Estimate
-0.61
Earnings History > 30 > eps Difference
0.04
Earnings History > 30 > surprise Percent
6.5574
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-04-30
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.59
Earnings History > 31 > eps Estimate
-0.74
Earnings History > 31 > eps Difference
0.15
Earnings History > 31 > surprise Percent
20.2703
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-14
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.91
Earnings History > 32 > eps Estimate
-0.77
Earnings History > 32 > eps Difference
-0.14
Earnings History > 32 > surprise Percent
-18.1818
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-01
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.4
Earnings History > 33 > eps Estimate
-0.63
Earnings History > 33 > eps Difference
0.23
Earnings History > 33 > surprise Percent
36.5079
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-08
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.75
Earnings History > 34 > eps Estimate
-0.67
Earnings History > 34 > eps Difference
-0.08
Earnings History > 34 > surprise Percent
-11.9403
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-09
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
BeforeMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.75
Earnings History > 35 > eps Estimate
-0.6
Earnings History > 35 > eps Difference
-0.15
Earnings History > 35 > surprise Percent
-25
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-15
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.51
Earnings History > 36 > eps Estimate
-0.56
Earnings History > 36 > eps Difference
0.05
Earnings History > 36 > surprise Percent
8.9286
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-22
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
BeforeMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.54
Earnings History > 37 > eps Estimate
-0.79
Earnings History > 37 > eps Difference
0.25
Earnings History > 37 > surprise Percent
31.6456
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-25
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.77
Earnings History > 38 > eps Estimate
-0.78
Earnings History > 38 > eps Difference
0.01
Earnings History > 38 > surprise Percent
1.2821
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-05-31
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
BeforeMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.83
Earnings History > 39 > eps Estimate
-0.73
Earnings History > 39 > eps Difference
-0.1
Earnings History > 39 > surprise Percent
-13.6986
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-11-30
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
BeforeMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-1.08
Earnings History > 40 > eps Estimate
-0.58
Earnings History > 40 > eps Difference
-0.5
Earnings History > 40 > surprise Percent
-86.2069
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-08-27
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
BeforeMarket
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.87
Earnings History > 41 > eps Estimate
0.49
Earnings History > 41 > eps Difference
-1.36
Earnings History > 41 > surprise Percent
-277.551
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-04-06
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
BeforeMarket
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.77
Earnings History > 42 > eps Estimate
-0.62
Earnings History > 42 > eps Difference
-0.15
Earnings History > 42 > surprise Percent
-24.1935
Earnings History > 43 > period
2014-09-30
Earnings History > 43 > report Date
2014-12-01
Earnings History > 43 > date
2014-09-30
Earnings History > 43 > before After Market
BeforeMarket
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.68
Earnings History > 43 > eps Estimate
-0.64
Earnings History > 43 > eps Difference
-0.04
Earnings History > 43 > surprise Percent
-6.25
Earnings History > 44 > period
2014-06-30
Earnings History > 44 > report Date
2014-09-02
Earnings History > 44 > date
2014-06-30
Earnings History > 44 > before After Market
BeforeMarket
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.7
Earnings History > 44 > eps Estimate
-0.56
Earnings History > 44 > eps Difference
-0.14
Earnings History > 44 > surprise Percent
-25
Earnings History > 45 > period
2014-03-31
Earnings History > 45 > report Date
2014-06-06
Earnings History > 45 > date
2014-03-31
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.71
Earnings History > 45 > eps Estimate
-0.45
Earnings History > 45 > eps Difference
-0.26
Earnings History > 45 > surprise Percent
-57.7778
Earnings History > 46 > period
2013-12-31
Earnings History > 46 > report Date
2014-03-26
Earnings History > 46 > date
2013-12-31
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
USD
Earnings History > 46 > eps Actual
-0.4945
Earnings History > 46 > eps Estimate
-
Earnings History > 46 > eps Difference
0
Earnings History > 46 > surprise Percent
-
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AQURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm NewMediaWire
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$58.7856
Analyst Picks
Strong Buy
9
Buy
2
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 92.28% of the total shares of Uniqure NV
1.
RTW INVESTMENTS, LLC(9.4013%)
since
2025/06/30
2.
EcoR1 Capital, LLC(7.2703%)
since
2025/06/30
3.
Vestal Point Capital LP(6.7436%)
since
2025/06/30
4.
venBio Select Advisor LLC(6.6069%)
since
2025/06/30
5.
Aberdeen Group PLC(5.0134%)
since
2025/06/30
6.
Jefferies Financial Group Inc(3.82%)
since
2025/06/30
7.
Nantahala Capital Management, LLC(3.7397%)
since
2025/06/30
8.
JPMorgan Chase & Co(3.2947%)
since
2025/06/30
9.
Franklin Resources Inc(2.9262%)
since
2025/06/30
10.
Sofinnova Ventures(2.8402%)
since
2025/06/30
11.
abrdn Healthcare Investors(2.7891%)
since
2025/08/31
12.
Integral Health Asset Management, LLC(2.4605%)
since
2025/06/30
13.
BlackRock Inc(2.4307%)
since
2025/06/30
14.
683 Capital Management LLC(2.342%)
since
2025/06/30
15.
FMR Inc(2.1586%)
since
2025/06/30
16.
State Street Corp(2.0829%)
since
2025/06/30
17.
Franklin Biotechnology Discv A(acc)USD(1.8891%)
since
2025/08/31
18.
Vanguard Group Inc(1.7728%)
since
2025/06/30
19.
Two Sigma Investments LLC(1.715%)
since
2025/06/30
20.
Morgan Stanley - Brokerage Accounts(1.6554%)
since
2025/06/30
21.
Boxer Capital Management, LLC(1.6394%)
since
2025/06/30
22.
JPMorgan Small Cap Growth A(1.6084%)
since
2025/07/31
23.
SPDR® S&P Biotech ETF(1.5279%)
since
2025/08/31
24.
Ameriprise Financial Inc(1.3887%)
since
2025/06/30
25.
abrdn World Healthcare(1.3426%)
since
2025/07/31
26.
Macquarie Healthcare I(1.2871%)
since
2025/07/31
27.
abrdn Life Sciences Investors(1.2844%)
since
2025/08/31
28.
Franklin Biotechnology Discovery A(1.0367%)
since
2025/07/31
29.
MEDICAL BioHealth EUR Acc(1.0104%)
since
2025/06/30
30.
Vanguard Institutional Extnd Mkt Idx Tr(1.0042%)
since
2025/07/31
31.
Fidelity Select Biotechnology(0.7563%)
since
2025/07/31
32.
International Biotechnology Ord(0.7444%)
since
2025/07/31
33.
Columbia Small Cap Value Discv A(0.713%)
since
2025/07/31
34.
Columbia Small Cap Value Discovery Fund(0.6935%)
since
2025/06/30
35.
Strategic Advisers Fidelity US TtlStk(0.6904%)
since
2025/07/31
36.
Fidelity Select Pharmaceuticals Port(0.6527%)
since
2025/07/31
37.
iShares Biotechnology ETF(0.5419%)
since
2025/08/31
38.
Fidelity Extended Market Index(0.5022%)
since
2025/07/31
39.
JPM Thematics Genetic Thrps C2 dist USD(0.461%)
since
2025/07/31
40.
Schwab US Small-Cap ETFâ„¢(0.4445%)
since
2025/08/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.9068
Date
2025-09-30
EPS Actual
-1.38
EPS Estimate
-0.91
EPS Difference
-0.47
Surprise Percent
-51.6484%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.